metabolism by serial measurements of thyroid hormones in the blood. This is inappropriate because it ignores the critical role of TSH in evaluating the bioequivalence of the far more critical tissue effects of thyroid hormones.
We urge the FDA to separately consider this question with experts in the field of biochemical measurements in thyroid disease.
Thank you for your attention.
DR. KIBBE: Thank you, Dr. Wood.
Our next speaker is Dr. Jacob Robbins.
DR. ROBBINS: I'm Dr. Jacob Robbins. I'm presenting the statement of the American Thyroid Association. I'm Scientist Emeritus at NIH and former President of the association.
The American Thyroid Association is a professional society of 900 U.S. and international physicians and scientists who specialize in research and treatment of thyroid diseases. In fair disclosure, the ATA acknowledges having received unrestricted financial support from companies which produce levothyroxine products, Abbott Labs and Jones-Pharma.
Today's review of bioequivalence for